Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Betterlife Pharma Inc (BETRF)

Betterlife Pharma Inc (BETRF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 7,202
  • Shares Outstanding, K 51,446
  • Annual Sales, $ 0 K
  • Annual Income, $ -9,710 K
  • 60-Month Beta 2.90
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BETRF with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.08
  • Most Recent Earnings -0.03 on 06/28/22
  • Next Earnings Date 09/22/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0834 +66.43%
on 07/13/22
0.1698 -18.26%
on 08/09/22
+0.0508 (+57.73%)
since 07/11/22
3-Month
0.0510 +172.16%
on 06/30/22
0.1698 -18.26%
on 08/09/22
+0.0550 (+65.63%)
since 05/11/22
52-Week
0.0510 +172.16%
on 06/30/22
0.3000 -53.73%
on 11/16/21
-0.0975 (-41.26%)
since 08/11/21

Most Recent Stories

More News
BetterLife To Participate at the H.C. Wainwright 1st Annual Mental Health Conference

VANCOUVER, British Columbia, June 23, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:...

BETR.CN : 0.170 (-5.56%)
BETRF : 0.1388 (-0.86%)
BetterLife To Present BETR-001 Preclinical Data at the Upcoming Canadian Association for Neuroscience Conference

VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:...

BETR.CN : 0.170 (-5.56%)
BETRF : 0.1388 (-0.86%)
BetterLife Obtains In Vivo PK Data for BETR-001 Confirming its Bioavailability in Brain

VANCOUVER, British Columbia, March 16, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:...

BETR.CN : 0.170 (-5.56%)
BETRF : 0.1388 (-0.86%)
BetterLife Launches New Corporate Website

VANCOUVER, British Columbia, Feb. 10, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR/ OTCQB: BETRF/ FRA:...

BETR.CN : 0.170 (-5.56%)
BETRF : 0.1388 (-0.86%)
BetterLife Obtains Positive In Vivo Oral Bioavailability, Food Effect and Pharmacokinetics Data for BETR-001

VANCOUVER, British Columbia, Jan. 18, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:...

BETR.CN : 0.170 (-5.56%)
BETRF : 0.1388 (-0.86%)
Dr. Eleanor Fish, Advisory Board Member, Awarded Order of Canada

VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:...

BETR.CN : 0.170 (-5.56%)
BETRF : 0.1388 (-0.86%)
BetterLife’s Wholly-Owned Subsidiary, Altum Pharmaceuticals, Obtains Non-Dilutive Financing Commitment From Strategic Investor!

VANCOUVER, British Columbia, Dec. 22, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:...

BETR.CN : 0.170 (-5.56%)
BETRF : 0.1388 (-0.86%)
H.C. Wainwright 2nd Annual Psychedelics Conference, BACK TO THE FUTURE!

VANCOUVER, British Columbia, Dec. 03, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:...

BETR.CN : 0.170 (-5.56%)
BETRF : 0.1388 (-0.86%)
Developing Psychedelic Medicine Beyond What We Already Know!

VANCOUVER, British Columbia, Nov. 05, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:...

BETR.CN : 0.170 (-5.56%)
BETRF : 0.1388 (-0.86%)
KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Viewing

/PRNewswire/ -- Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the presentations from the KCSA Psychedelics...

PSIL : 3.19 (-1.39%)
AWKNF : 0.4500 (-5.66%)
ENVB : 6.78 (+5.12%)
MCURF : 0.0510 (-7.27%)
NVMDF : 0.2700 (+35.00%)
BETRF : 0.1388 (-0.86%)
HUGE : 0.9600 (+3.23%)
MSSTF : 0.3500 (+16.67%)
PSYBF : 0.0569 (-4.21%)
PSYCF : 0.1048 (-10.81%)
BMBIF : 7.9800 (-1.85%)
NMDBF : 0.0685 (+20.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 0.1834
2nd Resistance Point 0.1680
1st Resistance Point 0.1534
Last Price 0.1388
1st Support Level 0.1234
2nd Support Level 0.1080
3rd Support Level 0.0934

See More

52-Week High 0.3000
Fibonacci 61.8% 0.2049
Fibonacci 50% 0.1755
Fibonacci 38.2% 0.1461
Last Price 0.1388
52-Week Low 0.0510

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar